SAB

Vial Announces the Addition of Dr. Egilius L.H. Spierings of MedVadis Research Corporation to their Central Nervous System Scientific Advisory Board

Vial Announces the Addition of Dr. Egilius L.H. Spierings of MedVadis Research Corporation to their Central Nervous System Scientific Advisory Board

Leave a Comment / Press Releases /

San Francisco, CA. March 8, 2022 — Vial, a global tech-first CRO providing next-generation clinical trial management services, announced the addition of Egilius L.H. Spierings, MD, Ph.D., to Vial’s central nervous system (CNS) scientific advisory board (SAB). Dr. Spierings will work closely with the company’s leadership team to shape the scientific strategy of Vial’s Neurology […]

Vial Announces the Addition of Dr. Egilius L.H. Spierings of MedVadis Research Corporation to their Central Nervous System Scientific Advisory Board Read More »

Dr. Tepper, professor of neuroscience at the University of Cambridge.

Vial Welcomes Dr. Stewart Tepper of the Geisel School of Medicine at Dartmouth College to their Central Nervous System Scientific Advisory Board.

Leave a Comment / Press Releases /

San Francisco, CA. January 16, 2023 — Vial, a tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Stewart J. Tepper, MD, FAHS, as a new CNS scientific advisor to their Neurology CRO. “We are delighted to welcome Dr. Tepper to our CNS SAB. We are grateful for his scientific contributions as we continue to expand our

Vial Welcomes Dr. Stewart Tepper of the Geisel School of Medicine at Dartmouth College to their Central Nervous System Scientific Advisory Board. Read More »

Dr. Jacqueline France, also known as Dr. French, proudly announces her membership in the scientific advisory board.

Vial Announces New Central Nervous System Scientific Advisory Board Member, Dr. Jacqueline French of the Epilepsy Study Consortium and NYU Grossman School of Medicine.

Leave a Comment / Press Releases /

San Francisco, CA. January 12, 2023 — Vial, a tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Jacqueline French, MD, as a new CNS scientific advisor to their Neurology CRO. Dr. French is a professor of neurology at the NYU Grossman School of Medicine, co-director of epilepsy clinical trials for NYU

Vial Announces New Central Nervous System Scientific Advisory Board Member, Dr. Jacqueline French of the Epilepsy Study Consortium and NYU Grossman School of Medicine. Read More »

Dr. Christopher Sweeney's announcement of his scientific advisory board.

Vial Announces the Addition of Dr. Christopher Sweeney of SAiGENCI and the University of Adelaide to their Oncology CRO Scientific Advisory Board

Leave a Comment / Press Releases /

San Francisco, CA. December 19, 2022 — Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Christopher Sweeney, MBBS, to Vial’s scientific advisory board (SAB). Dr. Sweeney will work closely with the company’s leadership team to shape the scientific strategy of Vial’s Oncology CRO products and services. “We are beyond thrilled that an eminent scientist

Vial Announces the Addition of Dr. Christopher Sweeney of SAiGENCI and the University of Adelaide to their Oncology CRO Scientific Advisory Board Read More »

Dr. Goadsby joins Vial's Neurology CRO Scientific Advisory Board.

Dr. Peter Goadsby of the NIHR Wellcome Trust at the King’s College Clinical Research Facility, London, Joins Vial’s Neurology CRO as a Scientific Advisor

Leave a Comment / Press Releases /

San Francisco, CA. December 14, 2022 — Vial, a global tech-enabled CRO providing next-generation clinical trial management services, welcomes Dr. Peter Goadsby as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Goadsby is the Director of the NIHR Wellcome Trust at the King’s College Clinical Research Facility, London, and a Professor of Neurology at

Dr. Peter Goadsby of the NIHR Wellcome Trust at the King’s College Clinical Research Facility, London, Joins Vial’s Neurology CRO as a Scientific Advisor Read More »

Dr. Veral Sheth, MD, PhD is an ophthalmology expert specializing in clinical research and trials as a CRO.

Vial Announces the Addition of Dr. Veeral Sheth of the University Retina and Macula Associates and the University of Illinois, Chicago, to their Ophthalmology CRO Scientific Advisory Board

Leave a Comment / Press Releases /

San Francisco, CA. December 13, 2022 — Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Veeral Sheth, MD, MBA, to Vial’s scientific advisory board (SAB). Dr. Sheth will work closely with the company’s leadership team to shape the scientific strategy of the Vial Ophthalmology CRO’s products and services. “We are elated for Dr. Sheth

Vial Announces the Addition of Dr. Veeral Sheth of the University Retina and Macula Associates and the University of Illinois, Chicago, to their Ophthalmology CRO Scientific Advisory Board Read More »

Dr. Lawlor of the Medical College of Wisconsin.

Vial Announces the Addition of Dr. Michael W. Lawlor of the Medical College of Wisconsin and the Diverge Translational Science Laboratory to their Central Nervous System Scientific Advisory Board

Leave a Comment / Press Releases /

San Francisco, CA. December 6, 2022 — Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Michael W. Lawlor, MD, Ph.D., to Vial’s central nervous system (CNS) scientific advisory board (SAB). Dr. Lawlor will work closely with the company’s leadership team to shape the scientific strategy of Vial’s Neurology CRO products and services. “We are

Vial Announces the Addition of Dr. Michael W. Lawlor of the Medical College of Wisconsin and the Diverge Translational Science Laboratory to their Central Nervous System Scientific Advisory Board Read More »

Dr. Adam Friedman joins Vial's Dermatology CRO

Vial Announces the Addition of Dr. Adam Friedman of the George Washington University School of Medicine and Health Sciences to their Dermatology CRO Scientific Advisory Board

Leave a Comment / Press Releases /

San Francisco, CA. November 29, 2022 — Vial, a tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Adam Friedman, MD, to their Scientific Advisory Board. Dr. Friedman will advise Vial on enhancing its Dermatology CRO product and services. “We are thrilled to welcome Dr. Friedman to our SAB. We are confident he will contribute relevant and informed counsel to

Vial Announces the Addition of Dr. Adam Friedman of the George Washington University School of Medicine and Health Sciences to their Dermatology CRO Scientific Advisory Board Read More »

Vial welcomes Dr. Rajesh Pahwa to their Neurology CRO.

Vial Welcomes Dr. Rajesh Pahwa, Chief of the Parkinson’s and Movement Disorder Division at the University of Kansas Medical Center, to its Central Nervous System Scientific Advisory Board

Leave a Comment / Press Releases /

San Francisco, CA. November 16, 2022 — Vial welcomes Rajesh Pahwa, MBBS, MD, as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Pahwa is Chief of the Parkinson’s and Movement Disorder Division and a professor of neurology at the University of Kansas Medical Center, which has been designated as one of 33 Centers

Vial Welcomes Dr. Rajesh Pahwa, Chief of the Parkinson’s and Movement Disorder Division at the University of Kansas Medical Center, to its Central Nervous System Scientific Advisory Board Read More »

CRO

Resources

Company

Sign up for Newsletter

By submitting, you are agreeing to our terms and privacy policy

© 2024 Vial. All rights reserved